AI assistant
Sending…
Genus PLC — Regulatory Filings 2013
Jun 4, 2013
4873_mrq_2013-06-04_da4e74b2-e156-453e-b579-71a635d5101e.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2285G
Genus PLC
04 June 2013
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | |||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
Genus Plc GB0002074580 |
||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | X | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Norges Bank | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | N/A | ||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
31 May 2013 | ||||
| 6. Date on which issuer notified: | 3 June 2013 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
Above 4% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| GB0002074580 | 2,414,172 | 2,414,172 | 2,443,597 | 2,443,597 | 4.03% | |||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
| N/A | N/A | N/A | N/A | N/A | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| N/A | N/A | N/A | N/A | N/A | Nominal | Delta | ||||||||||
| N/A | N/A | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 2,443,597 | 4.03% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| N/A | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | Norges Bank | |
| 11. Number of voting rights proxy holder will cease to hold: |
N/A | |
| 12. Date on which proxy holder will cease to hold voting rights: |
N/A | |
| 13. Additional information: | None | |
| 14. Contact name: | Stanislav Boiadjiev | |
| 15. Contact telephone number: | +47 2407 3142 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGIGDLIGGBGXS
More from Genus PLC
Director's Dealing
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Director's Dealing
2026
Apr 13
Director's Dealing
2026
Apr 1
Major Shareholding Notification
2026
Mar 10
Director's Dealing
2026
Mar 4
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Feb 27
Interim / Quarterly Report
2026
Feb 26
Regulatory Filings
2026
Feb 2